You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 12, December 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

T-Lymphocyte Subsets in the Lesional Skin of Allogeneic and Autologous Bone Marrow Transplant Patients

Amy S. Paller, MD; Ann Nelson; Laura Steffen, MD; Lisa Gottschalk, PhD; Herbert Kaizer, MD, PhD

Arch Dermatol. 1988;124(12):1795-1801.


Abstract

• Cutaneous biopsy specimens obtained from bone marrow transplant (BMT) patients, most with graft-vshost disease (GVHD), were analyzed for infiltration by helper, cytotoxic, and suppressor T lymphocytes and natural killer cells. Lesional skin from patients with early mild GVHD and drug reactions showed a CD4/CD8 ratio of 5.0 or more, but later biopsy specimens from patients with acute GVHD and the majority of sections from those with chronic GVHD showed a CD4/CD8 ratio of 0.8 to 3.0 due to increased numbers of presumably cytotoxic cells. Significant numbers of suppressor (CD11 + CD16b-) cells were found in only one patient with severe chronic GVHD. Natural killer cells were not found. Preliminary examination of lesional skin from seven autologous BMT patients showed a similar trend of decreased CD4/CD8 ratios in the three patients with a syndrome that resembled GVHD. Analysis of CD4/CD8 ratios in serial biopsy specimens from patients with GVHD may allow more accurate monitoring of the progression of cutaneous GVHD and may help to elucidate the mechanism of development of the GVHD-like reaction in autologous BMT patients.

(Arch Dermatol 1988;124:1795-1801)



Author Affiliations

From the Departments of Dermatology (Drs Paller and Steffen and Ms Nelson), Immunology and Microbiology (Drs Paller and Gottschalk), and Medicine (Dr Kaizer), Rush University of Rush-Presbyterian-St Luke's Medical Center, Chicago. Dr Paller is now with the Division of Dermatology, The Children's Memorial Hospital, Chicago.


Footnotes

Accepted for publication May 27, 1988.

Reprint requests to Division of Dermatology, The Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614 (Dr Paller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cutaneous Graft-versus-Host Disease
Aractingi and Chosidow
Arch Dermatol 1998;134:602-612.
ABSTRACT | FULL TEXT  

Immunopathology of Toxic Epidermal Necrolysis: Keratinocytes, HLA-DR Expression, Langerhans Cells, and Mononuclear Cells: An Immunopathologic Study of Five Cases
Villada et al.
Arch Dermatol 1992;128:50-53.
ABSTRACT  

T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis: Possible Pathogenic Mechanism Induced by CD8-Positive T Cells
Miyauchi et al.
Arch Dermatol 1991;127:851-855.
ABSTRACT  

Acute Graft-vs-Host Disease in an Immunodeficient Newborn Possibly due to Cytomegalovirus Infection
Tawfik and Jimbow
Arch Dermatol 1989;125:1685-1688.
ABSTRACT  

Cutaneous Eruptions of Lymphocyte Recovery
Horn et al.
Arch Dermatol 1989;125:1512-1517.
ABSTRACT  

The Discrimination Between CD8+ Cytotoxic and CD8+ Suppressor Lymphocyte Subsets Within Cutaneous Infiltrates
Panfilis
Arch Dermatol 1989;125:844-845.
ABSTRACT  

The Graft-vs-Host Reaction: An Iatrogenic Model for a Number of Skin Disorders
Goltz
Arch Dermatol 1988;124:1849-1850.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.